Journal of Haehwa Medicine (혜화의학회지)

Research Institute of Korean Medicine (대전대학교 한의학연구소)
권호 표지

A comparative study on physiopathology of depression by Korean medicine and conventional medicine

우울증의 병태생리에 관한 동서의학적 비교

  • Oh, Hyeon-Muk (College of Korean medicine, Daejeon University) ;
  • Kim, Seo-Woo (College of Korean medicine, Daejeon University) ;
  • Oh, Young-Taeck (College of Korean medicine, Daejeon University) ;
  • Son, Chang-Gue (Liver-Immune Department of Oriental Medicine College, Daejeon University) ;
  • Lee, Jin-Seok (Liver-Immune Department of Oriental Medicine College, Daejeon University)
  • 오현묵 (대전대학교 한의학과) ;
  • 김서우 (대전대학교 한의학과) ;
  • 오영택 (대전대학교 한의학과) ;
  • 손창규 (대전대학교 한의과대학 간장면역학교실) ;
  • 이진석 (대전대학교 한의과대학 간장면역학교실)
  • Received : 2017.08.03
  • Accepted : 2017.08.16
  • Published : 2017.09.20
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: This study aims to summarize recent findings of depression and compare the physiopathology of depression by conventional medicine and Korean medicine. Methods: A literature search of PubMed and Journal of Oriental Neuropsychiatry was conducted. This study analyzes the physiopathology of depression. Results: Despite difference of the viewpoints between conventional medicine and Korean medicine, etiology and symptoms of depression are similar. Recent findings of depression partly accord with Korean medicine theory. Conclusion: Physiopathology of depression has yet to be completely understood and current treatments remain ineffective in a large subset of patients. As the efficacy of Korean medicine against depression is demonstrating recently, understanding the viewpoints of Korean medicine will provide new perspectives and hints for further research and therapeutic development.

Keywords

References

  1. Oh BH. Diagnosis and treatment of elderly depression. Journal of the Korean Medical Association. 2003 ; 46 : 808-14. https://doi.org/10.5124/jkma.2003.46.9.808
  2. Hillhouse TM, Porter JH. A brief history of the development of antidepressant drugs: from monoamines to glutamate. Experimental and Clinical Psychopharmacology. 2015 ; 23(1) : 1-21. https://doi.org/10.1037/a0038550
  3. Madhukar HT, Rush AJ, Stephen RW, Andrew AN, Warden D, Ritz L et al. Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D. Am J Psychiatry 2006 ; 163 : 28-40. https://doi.org/10.1176/appi.ajp.163.1.28
  4. Lee EH, Jung IC. Anti-Depressive Effects of OnDam-Tang with Addition of Linderae Radix (ODT-L) after Chronic Immobilization Stress in C57BL/6 Mice. Korean J. Oriental Physiology & Pathology 2014 ; 28(4) : 403-410.
  5. Lee SH, Kim BY, Kee JI, Kwen SJ, Chung DK. A Case of Mixed Anxiety and Depressive Disorder. Journal of Oriental Neuropsychiatry. 2003 ; 14(2) : 127-34.
  6. Mao QQ, Ip SP, Xian YF, Hu Z, Che CT. Anti-depressant-like effect of peony: a mini-review, Pharmaceutical Biology. 2012 ; 50 : 1, 72-77.
  7. Dang H, Chen Y, Liu X, Wang Q, Wang L, Jia W, Wang Y. Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2009 ; 33 : 1417-1424. https://doi.org/10.1016/j.pnpbp.2009.07.020
  8. Li YH, Kim DH, Lee TH. Effect of Mixture extracted from Bupleuri Radix and Physalidis Herba on the LPS-induced depression in Rats. The Korea journal of herbology. 2015 ; 30(3) : 69-76. https://doi.org/10.6116/kjh.2015.30.3.69.
  9. Jung MH. Anti-stress effects of Sihosogansan in the passive avoidance test and the forced swimming test. The Korea journal of herbology 2007 ; 22(2) : 127-134.
  10. Wang Y, Fan R, Huang X. Meta-analysis of the clinical effectiveness of traditional Chinese medicine formula Chaihu-Shugan-San in depression. J Ethnopharmacol. 2012 ; 141(2) : 571-7 https://doi.org/10.1016/j.jep.2011.08.079
  11. Woo JA, Nam YJ, Park YJ, Kwon YK. Review of Recent Clinical Trials for Depression in Traditional Chinese Medicine:Based on Randomized Controlled Trials and Systematic Reviews. J Physiol & Pathol Korean Med 2015 ; 29(6) : 458-466. https://doi.org/10.15188/kjopp.2015.12.29.6.458
  12. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. Arlington: American Psychiatric Association, 2013.
  13. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003 ; 289 : 3095-3105. https://doi.org/10.1001/jama.289.23.3095
  14. Lee EH, Choi WC, Jung IC. Preliminary Study to Develop the Instrument on Pattern Identifications for Depression. J of Oriental Neuropsychiatry. 2013 ; 24(4) : 435-450. https://doi.org/10.7231/jon.2013.24.4.435
  15. Kang HW, Jang HH, Kang IS, Moon HC, Hwang YJ, Lyu YS. A study on the Oriental-medical understanding of depression. J of Oriental Neuropsychiatry. 2001 ; 12(2) : 1-15.
  16. Han YS. Study on the antidepressant effect of the modified storax pill by oral administration and aroma therapy. Dong-guk university. 2007 ; 44.
  17. Ryu JM, Hwang UW, Kim JW, Chi SE, Kim EJ, Park EH. The effects of Jowiseungchungtang versus fluoxetine in the chronic mild stress model of depression in rats. J of Oriental Neuropsychiatry. 2004 ; 15(1) : 43-64.
  18. Hwangyuwan. Syunclein medicine. Seoul:Modern Medical books. 1987 : 505-529, 607-611.
  19. Korean Oriental Neuropsychiatric Association. Oriental Neuropsychiatry. Gyeong-gi:jipmoon. 2005 : 254-6, 482-6.
  20. Lee SH, Kim BY, Kee JI, Kwen SJ, Chung DK. A Case of Mixed Anxiety and Depressive Disorder. Journal of Oriental Neuropsychiatry. 2003 ; 14(2) : 127-34.
  21. Dean J, Keshavan M. The Neurobiology of Depression: an Integrated View. Asian Journal of Psychiatry 2017 ; 27 : 101-111. https://doi.org/10.1016/j.ajp.2017.01.025
  22. Nestler EJ, Barrot, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LS. Neurobiology of depression. Neuron. 2002 ; 34 : 13-25. https://doi.org/10.1016/S0896-6273(02)00653-0
  23. Baldinger P, Lotan A, Frey R, Kasper S, Lerer B, Lanzenberger R. Neurotransmitters and electroconvulsive therapy. J ECT 2014 ; 30 : 116-121. https://doi.org/10.1097/YCT.0000000000000138
  24. Haase, J, Brown E. Integrating the monoamine, neurotrophin and cytokine hypotheses of depression - A central role for the serotonin transporter?. Pharmacology & Therapeutics. 2015 ; 147 : 1-11. https://doi.org/10.1016/j.pharmthera.2014.10.002
  25. Capuron L, Miller AH. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther. 2011 ; 130 : 226-238. https://doi.org/10.1016/j.pharmthera.2011.01.014
  26. Khairova RA, Machado-Vieira R, Du J, Manji HK. A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol. 2009 ; 12 : 561-578. https://doi.org/10.1017/S1461145709009924
  27. Kubera M, Obuchowicz E, Goehler L, Brzeszcz J, Maes M. In animal models, psychosocial stress- induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011 ; 35 : 744-759. https://doi.org/10.1016/j.pnpbp.2010.08.026
  28. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008 ; 9 : 46-56. https://doi.org/10.1038/nrn2297
  29. Menard C, Hodes GE, Russo SJ. Pathogenesis of depression: insights from human and rodent studies, Neuroscience. 2016 ; 321 : 138-162. https://doi.org/10.1016/j.neuroscience.2015.05.053
  30. Teper E, O'Brien JT. Vascular factors and depression. Int J Geriatr Psychiatry. 2008 ; 23 : 993-1000. https://doi.org/10.1002/gps.2020
  31. Newton SS, Fournier NM, Duman RS. Vascular growth factors in neuropsychiatry. Cell Mol Life Sci. 2013 ; 70 : 1739-1752. https://doi.org/10.1007/s00018-013-1281-9
  32. Kolb B, Whishaw IQ. Fundamentals of Human Neuropsychology. New York : N.Y Worth Publishers 2009.
  33. Mulligan SJ, MacVicar BA. Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature. 2004 ; 431 : 195-199. https://doi.org/10.1038/nature02827
  34. Argaw AT, Asp L, Zhang J, Navrazhina K, Pham T, Mariani JN, Mahase S, Dutta DJ, Seto J, Kramer EG, Ferrara N, Sofroniew MV, John GR. Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. J Clin Invest. 2012 ; 122 : 2454- 2468. https://doi.org/10.1172/JCI60842
  35. Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR. VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci U S A. 2009 ; 106 : 1977-1982. https://doi.org/10.1073/pnas.0808698106
  36. Warner-Schmidt JL, Duman RS. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci USA. 2007 ; 104 : 4647-4652. https://doi.org/10.1073/pnas.0610282104
  37. Wedrychowicz A, Zajac A, Pilecki M, Koscielniak B, Tomasik PJ. Peptides from adipose tissue in mental disorders. World J. Psychiatry. 2014 ; 4:103-111. https://doi.org/10.5498/wjp.v4.i4.103
  38. Duman RS, Aghajanian GK, Sanacora G, Krystal JH. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. 2016 ; 22(3) : 238-249. https://doi.org/10.1038/nm.4050
  39. Agudelo, L.Z. et al. Skeletal muscle PGC-1 1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell. 2014 ; 159: 33-45. https://doi.org/10.1016/j.cell.2014.07.051
  40. Foster JA, Neufeld KAMV. Gut-brain axis: how the microbiome influences anxiety and depression. Trends in Neurosciences. 2013 ; 36(5) : 305-312. https://doi.org/10.1016/j.tins.2013.01.005
  41. Kim YH, Kim IR, Chi GY. A study on interpretative basis of brain as a place of mental function in oriental medicine. Korean J Oriental Physiology & Pathology. 2002 ; 16(5) : 881-887.
  42. Korean Society of Oriental Neuropsychiatry., Oriental Neuropsychiatry texbook, 경기:집문당. 2005 : 251.
  43. The CPG compilation committee for EBM-based dpression. CPG for Oriental treatments of depression. Daejeon, Korea. 2015
  44. Seong WY. A Study of Chiljeong in the Canon of Internal Medicine. J of Oriental Neuropsychiatry. 2013 ; 24(4) : 451-468. https://doi.org/10.7231/jon.2013.24.4.451